South Africa Anti-infective Agents Market Size & Outlook
South Africa anti-infective agents market, 2018-2030 (US$M)
Related Markets
South Africa anti-infective agents market highlights
- The South Africa anti-infective agents market generated a revenue of USD 829.6 million in 2024 and is expected to reach USD 935.7 million by 2030.
- The South Africa market is expected to grow at a CAGR of 2.5% from 2025 to 2030.
- In terms of segment, antivirals was the largest revenue generating type in 2024.
- Antifungals is the most lucrative type segment registering the fastest growth during the forecast period.
Anti-infective agents market data book summary
| Market revenue in 2024 | USD 829.6 million |
| Market revenue in 2030 | USD 935.7 million |
| Growth rate | 2.5% (CAGR from 2025 to 2030) |
| Largest segment | Antivirals |
| Fastest growing segment | Antifungals |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibacterials, Antivirals, Antifungals |
| Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.6% of the global anti-infective agents market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa anti-infective agents market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 935.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-infective Agents Market Scope
Anti-infective Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa anti-infective agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 35.27% in 2024. Horizon Databook has segmented the South Africa anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa's anti-infective agents market is experiencing growth driven by a rising prevalence of infectious diseases and significant governmental support for clinical trials and drug development. The country has one of the highest burdens of HIV and tuberculosis globally, making anti-infective drugs a critical component of healthcare strategy.
For instance, in 2022, the South African Health Products Regulatory Authority (SAHPRA) approved Apretude, marking it as the first and only long-acting option for preexposure prophylaxis to lower the risk of sexually acquired HIV-1. This regulatory framework supports a rigorous assessment of clinical trial data, which helps accelerate the availability of effective drugs.
Reasons to subscribe to South Africa anti-infective agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa anti-infective agents market databook
-
Our clientele includes a mix of anti-infective agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into South Africa anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa anti infective agents market size, by type, 2018-2030 (US$M)
South Africa Anti-infective Agents Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
